<DOC>
	<DOC>NCT00520832</DOC>
	<brief_summary>Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.</brief_summary>
	<brief_title>A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>Student, Faculty or Staff Age 18 40 Symptoms of primary insomnia No implanted electric devices No local infection, injury or malignancy No history of seizure or other neurological disorders No current use of prescription or other substances that could effect sleep quality or quantity Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Primary Insomnia</keyword>
	<keyword>Microcurrent Therapy</keyword>
	<keyword>Sleep Surveys</keyword>
</DOC>